Tina

A phase II trial of neoadjuvant MK2206, an AKT inhibitor, with anastrozole in clinical stage 2 or 3 PIK3CA mutant ER positive and HER2 negative breast cancer Estrogen receptor positive breast cancer, neoadjuvant endocrine therapy,

Erica K. Barnell, E. Mardis, O. Griffith, 2017 .

COVID-19 Vaccines Safety Tracking ( CoVaST ) : Protocol of a 2 Multi-center Prospective Cohort Study for Active Surveillance 3 of COVID-19 Vaccines Side Effects 4

C. Wiysonge, A. Qaseem, R. Kalda, 2021 .

Advances in Brief Comparative Genomic in Situ Hybridization of Colon Carcinomas with Replication Error '

H. Scherthan, J. Rüschoff, J. Schlegel, 2006 .